Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-27 @ 5:10 AM
Study NCT ID:
NCT05667493
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-12-12
First Post:
2022-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2029-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-12
First Submit QC Date:
None
Study First Post Date:
2022-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-12
Last Update Post Date Type:
ESTIMATED